CENTURY THERAPEUTICS
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer. The company's genetically-engineered, iPSC-derived immune effector cell products are designed to specifically target hematologic and solid cancers by harnessing the power of adult stem cells, providing patients with an unparalleled opportunity to advance the course of cancer care.
CENTURY THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics Therapeutics
Founded:
2018-03-05
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.centurytx.com
Total Employee:
101+
Status:
Active
Total Funding:
560 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS Amazon Virginia Region Barracuda Networks
Similar Organizations
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Novita Pharmaceuticals
Novita Pharmaceuticals is a developer of therapeutic drugs for the treatment of cancer.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2020-06-23 | Empirica Therapeutics | Empirica Therapeutics acquired by Century Therapeutics | N/A |
Investors List
Bristol Myers Squibb
Bristol Myers Squibb investment in Post-IPO Equity - Century Therapeutics
Logos Capital
Logos Capital investment in Series C - Century Therapeutics
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series C - Century Therapeutics
RA Capital Management
RA Capital Management investment in Series C - Century Therapeutics
Marshall Wace
Marshall Wace investment in Series C - Century Therapeutics
Qatar Investment Authority
Qatar Investment Authority investment in Series C - Century Therapeutics
Casdin Capital
Casdin Capital investment in Series C - Century Therapeutics
OrbiMed
OrbiMed investment in Series C - Century Therapeutics
Versant Ventures
Versant Ventures investment in Series C - Century Therapeutics
Avidity Partners
Avidity Partners investment in Series C - Century Therapeutics
Official Site Inspections
http://www.centurytx.com Semrush global rank: 4.98 M Semrush visits lastest month: 1.7 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago